Analyst firms · Argus Research · TDOC

Argus Research TDOC price target and rating history

Teladoc Health Inc. (TDOC) · Health Care

Argus Research rates Teladoc Health Inc. (TDOC) Sell with a $95 price target, as of its latest action on Nov 2, 2026. It has published 4 rating actions on TDOC since August 2021, including 1 upgrade and 3 downgrades. Across 3 firms with a TDOC price target in the last 12 months, the median target is $8.50.

Current rating
Sell
Price target
$95
Median target, all firms
$8.50
Actions on TDOC
4

Every Argus Research rating on TDOC

How other firms rate TDOC

Each firm's latest rating and stated target in the last 12 months.

FirmRatingPrice targetDate
Argus ResearchSellNov 2, 2026
Deutsche BankBuy$11Mar 10, 2026
BofA SecuritiesBuy$7Feb 26, 2026
BarclaysEqual Weight$8.50Dec 9, 2025

Questions about Argus Research and TDOC

What is Argus Research's price target for TDOC?
Argus Research's latest stated price target for Teladoc Health Inc. (TDOC) is $95, from its action on Mar 3, 2022.
What is Argus Research's rating on TDOC?
Argus Research rates TDOC Sell, a bearish rating, as of Nov 2, 2026.
When did Argus Research last change its view on TDOC?
On Nov 2, 2026, Argus Research downgrades to Sell from Hold.
How does Argus Research's TDOC target compare with other analysts?
Across 3 firms with a TDOC price target in the last 12 months, the median target is $8.50.

More TDOC rating histories

All Argus Research ratingsTDOC news and filingsEvery analyst firm

From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.